secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001104659-25-007610
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunome prices upsized $150M public offering of common stock at $7.75/share
----------------------------------------------------------------------------

- 19,354,839 shares priced at $7.75 per share; gross proceeds $150M.
- Underwriters granted 30-day option to buy up to 2,903,225 additional shares.
- Offering expected to close Jan 31, 2025, subject to customary closing conditions.
- Joint book-running managers: J.P. Morgan, TD Cowen, Leerink Partners, Guggenheim Securities.
- Offering upsized from initially announced $125M; all shares sold by Immunome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465925007610/0001104659-25-007610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465925007610/tm254657d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-007610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer